TAGRISSO 80 mg/1

TAGRISSO 80 mg is a medication used in cancer treatment. It contains osimertinib, a targeted therapy for specific genetic mutations. Learn more about its uses and effects.

TAGRISSO 80 mg is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. This medication targets the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. It is often prescribed for patients who have developed resistance to other EGFR-targeted therapies. What is TAGRISSO used for? It is used to manage advanced NSCLC in patients with EGFR T790M mutation-positive tumors.

Common effects of TAGRISSO 80 mg may include diarrhea, rash, dry skin, and nail problems. Some users may experience fatigue, cough, or changes in appetite. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

TAGRISSO 80 mg should be handled with care. Store it at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Follow the prescribed dosage and administration instructions provided by your healthcare provider.

TAGRISSO 80 mg may interact with certain medications, including those that are metabolized by the liver's CYP3A enzyme. Always inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.